A Call to Arms Over the New Claims and Continuations Rules?
Notable practitioner Gene Quinn (of IPWatchdog and PLI Blog fame) issued a press release today in an attempt to marshal support for the GlaxoSmithKline (GSK) challenge to the U.S. Patent Office claims and continuations rules. See a previous AT! post about the GSK complaint here. Mr. Quinn is firmly convinced that “the new patent rules will substantially change patent law and practice and negatively affect all companies and individuals who use the U.S. patent system.”
For those who want to analyze this matter further, there is also a great running post at the IPWatchdog that is chronicling the proceedings in the GSK case.
Your comments about this recent call to arms are welecomed!